JP2022534709A5 - - Google Patents
Info
- Publication number
- JP2022534709A5 JP2022534709A5 JP2021569992A JP2021569992A JP2022534709A5 JP 2022534709 A5 JP2022534709 A5 JP 2022534709A5 JP 2021569992 A JP2021569992 A JP 2021569992A JP 2021569992 A JP2021569992 A JP 2021569992A JP 2022534709 A5 JP2022534709 A5 JP 2022534709A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- alkyl
- alkyls
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962856822P | 2019-06-04 | 2019-06-04 | |
| US62/856,822 | 2019-06-04 | ||
| PCT/US2020/035851 WO2020247447A1 (en) | 2019-06-04 | 2020-06-03 | Pyrazole and imidazole derivatives, compositions and methods as orexin antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022534709A JP2022534709A (ja) | 2022-08-03 |
| JP2022534709A5 true JP2022534709A5 (enExample) | 2023-06-08 |
| JP7837120B2 JP7837120B2 (ja) | 2026-03-30 |
Family
ID=73651984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569992A Active JP7837120B2 (ja) | 2019-06-04 | 2020-06-03 | オレキシンアンタゴニストとしてのピラゾール及びイミダゾール誘導体、組成物、並びに方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20220315602A1 (enExample) |
| EP (1) | EP3972587A4 (enExample) |
| JP (1) | JP7837120B2 (enExample) |
| KR (1) | KR20220016919A (enExample) |
| CN (1) | CN114340616A (enExample) |
| AU (1) | AU2020288559C1 (enExample) |
| CA (1) | CA3140173A1 (enExample) |
| SG (1) | SG11202112828SA (enExample) |
| WO (1) | WO2020247447A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020286381C1 (en) | 2019-06-04 | 2025-07-10 | Hager Biosciences, Llc | Imidazolo derivatives, compositions and methods as orexin antagonists |
| MX2022007376A (es) | 2019-12-20 | 2022-09-02 | Tenaya Therapeutics Inc | Fluoroalqull-oxadiazoles y sus usos. |
| US20240252502A1 (en) | 2021-05-04 | 2024-08-01 | Tenaya Therapeutics, Inc. | Hdac6 inhibitors for treatment of metabolic disease and hfpef |
| US20260070922A1 (en) * | 2022-09-01 | 2026-03-12 | Hager Biosciences, Llc | Pyrazole and imidazole derivatives as dual orexin and kappa-opioid receptors modulators composition, methods for treating neurological and psychiatric disorders |
| CN118556061B (zh) * | 2022-11-23 | 2025-07-15 | 江苏恩华药业股份有限公司 | 一种二取代八氢吡咯并[3,4-c]吡咯甲基酮衍生物及其应用 |
| GB202311281D0 (en) | 2023-07-21 | 2023-09-06 | Bial Portela & Ca Sa | Orexin receptor antagonists |
| GB202311280D0 (en) | 2023-07-21 | 2023-09-06 | Bial Portela & Ca Sa | Orexin receptor antagonists |
| CN117169393B (zh) * | 2023-11-03 | 2024-03-19 | 杭州湃肽生化科技有限公司 | 一种植物组织中环肽的检测方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925849A (en) * | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
| UA85937C2 (uk) * | 2004-12-21 | 2009-03-10 | Пфайзер Продактс Інк. | Макроліди |
| AR067665A1 (es) * | 2007-07-27 | 2009-10-21 | Actelion Pharmaceuticals Ltd | Derivados de trans-3- aza-biciclo ( 3.1.0) hexano |
| US8614242B2 (en) * | 2010-10-21 | 2013-12-24 | Bayer Intellectual Property Gmbh | 1-(heterocyclic carbonyl)-2-substituted pyrrolidines |
| US20140228377A1 (en) * | 2011-07-05 | 2014-08-14 | Taisho Pharmaceutical Co., Ltd. | Methylpiperidine derivative |
| EP2771346A4 (en) * | 2011-10-25 | 2015-06-03 | Merck Sharp & Dohme | ISOXAZOLOPYRIDIN-orexin |
| CA2863413A1 (en) * | 2012-02-07 | 2013-08-15 | Eolas Therapeutics, Inc. | Substituted prolines / piperidines as orexin receptor antagonists |
| US10081624B2 (en) * | 2014-08-26 | 2018-09-25 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| MY205440A (en) * | 2018-09-28 | 2024-10-21 | Janssen Pharmaceutica Nv | Monoacylglycerol lipase modulators |
| AU2020286381C1 (en) * | 2019-06-04 | 2025-07-10 | Hager Biosciences, Llc | Imidazolo derivatives, compositions and methods as orexin antagonists |
-
2020
- 2020-06-03 AU AU2020288559A patent/AU2020288559C1/en not_active Expired - Fee Related
- 2020-06-03 KR KR1020217043401A patent/KR20220016919A/ko not_active Ceased
- 2020-06-03 CA CA3140173A patent/CA3140173A1/en active Pending
- 2020-06-03 SG SG11202112828SA patent/SG11202112828SA/en unknown
- 2020-06-03 EP EP20817900.2A patent/EP3972587A4/en not_active Withdrawn
- 2020-06-03 JP JP2021569992A patent/JP7837120B2/ja active Active
- 2020-06-03 CN CN202080056013.4A patent/CN114340616A/zh active Pending
- 2020-06-03 US US17/616,142 patent/US20220315602A1/en not_active Abandoned
- 2020-06-03 WO PCT/US2020/035851 patent/WO2020247447A1/en not_active Ceased
-
2024
- 2024-08-09 US US18/799,706 patent/US12275744B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022534709A5 (enExample) | ||
| JP2022534704A5 (enExample) | ||
| JP2022545633A5 (enExample) | ||
| WO2022261383A1 (en) | Novel prodrugs and conjugates of dimethyltryptamine | |
| JPS6084282A (ja) | １−ヘテロアリ−ル−４−〔（２．５−ピロリジンジオン−１−イル）アルキル〕ピペラジン誘導体 | |
| KR101907631B1 (ko) | 1,5-디페닐-펜타-1,4-디엔-3-온 화합물 | |
| CA3076202A1 (en) | Cyclic iminopyrimidine derivatives as kinase inhibitors | |
| PT605228E (pt) | Derivados tiazolidinadionas sua preparacao e sua utilizacao | |
| JP4740116B2 (ja) | 精神疾患および神経障害の処置のための５−ｈｔ受容体アンタゴニスト | |
| HU217590B (hu) | Eljárás 6-os helyen heterociklusos csoporttal helyettesített 4-amino-1,3,4,5-tetrahidro-benz[c,d]indolok és a vegyületeket tartalmazó gyógyszerkészítmények előállítására | |
| BR112020019708A2 (pt) | compostos como moduladores de sinalização de tlr2 | |
| JP2021520415A5 (enExample) | ||
| JP3521214B2 (ja) | ４，５−ジヒドロイソオキサゾリルアルキルピペラジン誘導体とその製造方法並びにドーパミン拮抗剤 | |
| EP4633625A2 (en) | Prodrugs of dimethyltryptamine and derivatives thereof | |
| WO2005080357A2 (fr) | Derives d’oxazole, leur preparation et leur utilisation en therapeutique | |
| JP6542236B2 (ja) | 有機化合物 | |
| HU199825B (en) | Process for production of new derivatives of pirasoline and medical compositions containing them | |
| JP6100755B2 (ja) | （２−ヘテロアリールアミノ）コハク酸誘導体 | |
| JPS62120374A (ja) | １，３−チアジンまたは１，３−オキサジン誘導体 | |
| WO2005035488A2 (fr) | Derives de thiophene-2-carboxamide et leurs utilisation comme antagonistes des recepteurs cb1 des cannabinoides | |
| JP2017516824A5 (enExample) | ||
| FR2899899A1 (fr) | Derives d'aminomethyl pyridine, leur preparation et leur application en therapeutique | |
| Dyachenko et al. | Multicomponent Synthesis of Nicotinamide and Thieno [2, 3-b] pyridine Derivatives | |
| JP3042915B2 (ja) | ３−（１ｈ−インダゾール−３−イル）−４−ピリジンアミンおよびその製造法 | |
| JPH0578554B2 (enExample) |